Effects of TNF and lymphotoxin on bone cells

Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth.

Leukemia·2017

Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.

Leukemia·2016

Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial.

Blood cancer journal·2016

Blocking the ZZ domain of sequestosome1/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo.

Leukemia·2015

Genetic polymorphisms of EPHX1, Gsk3beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma.

Leukemia·2009

Pathogenesis of myeloma bone disease.

Leukemia·2008

Lentivirus infection of macrophages.

Immunology series·1994

The macrophage and HIV-1.

Immunology series·1994

Macrophage-Cryptococcus interactions.

Immunology series·1994

Macrophage interactions with Candida.

Immunology series·1994

Macrophages in experimental Chagas' disease.

Immunology series·1994

Macrophages and Brucella.

Immunology series·1994

TGα2β-modified adipose-derived stem cell exosomes regulate collagen synthesis in fibroblasts and enhance chronic ulcerative wound repair through the ILK/AKT signaling pathway.

Pakistan journal of pharmaceutical sciences·2026

Rare Ovarian Sex Cord-Stromal Tumor: Diagnostic Pitfalls and Clinical Management.

Cureus·2026

Giant Breast Angiosarcoma in a 20-Year-Old Young Adult Female: A Case Report and Review of Literature.

Case reports in oncology·2026

Intracardiac Neoplastic Extension of a Malignant Solitary Fibrous Tumor Mimicking a Giant Left Atrial Thrombus.

Cureus·2026

GATA3 and TRPS1 Expression in Follicular Dendritic Cell Sarcoma.

International journal of surgical pathology·2026

Remodeling the Immune Landscape: How Obesity-Induced SASPs Create a Pro-Tumorigenic Niche.

Current obesity reports·2026

Related Experiment Videos

Effects of TNF and lymphotoxin on bone cells

Related Concept Videos

Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth.

Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.

Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial.

Blocking the ZZ domain of sequestosome1/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo.

Genetic polymorphisms of EPHX1, Gsk3beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma.

Pathogenesis of myeloma bone disease.

Lentivirus infection of macrophages.

The macrophage and HIV-1.

Macrophage-Cryptococcus interactions.

Macrophage interactions with Candida.

Macrophages in experimental Chagas' disease.

Macrophages and Brucella.

TGα2β-modified adipose-derived stem cell exosomes regulate collagen synthesis in fibroblasts and enhance chronic ulcerative wound repair through the ILK/AKT signaling pathway.

Rare Ovarian Sex Cord-Stromal Tumor: Diagnostic Pitfalls and Clinical Management.

Giant Breast Angiosarcoma in a 20-Year-Old Young Adult Female: A Case Report and Review of Literature.

Intracardiac Neoplastic Extension of a Malignant Solitary Fibrous Tumor Mimicking a Giant Left Atrial Thrombus.

GATA3 and TRPS1 Expression in Follicular Dendritic Cell Sarcoma.

Remodeling the Immune Landscape: How Obesity-Induced SASPs Create a Pro-Tumorigenic Niche.

Related Experiment Videos

Effects of TNF and lymphotoxin on bone cells

Related Concept Videos

Related Articles